DENTSPLY SIRONA Inc.
XRAYHealthcareNASDAQMedical Instruments & Supplies
Scan Results
Daily timeframeDENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. The company carries a $1.84B market cap, placing it firmly in the small-cap category. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare.
Market Cap
$1.84B
Beta
0.88
P/E (TTM)
—
P/E (Fwd)
6.24
EPS (TTM)
$-2.73
EPS (Fwd)
$1.48
ROE
-33.0%
ROA
2.0%
Cash
$239.0M
Total Debt
$2.33B
Free CF
$141.6M
52W Change
-29.6%
Annual Financials
Cash vs Debt
Where XRAY stands vs its 150-day and 200-day moving averages
As of the October 15, 2026 close, XRAY finished 24.03% below its 150-day moving average ($11.11) and 26.61% below its 200-day moving average ($11.50). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is XRAY overbought or oversold?
At the October 15, 2026 close, XRAY's RSI(14) was 18.1, in oversold territory (below 30). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
DENTSPLY SIRONA Inc. carries $2.33B in total debt against $239.0M in cash reserves — debt is roughly 9.7x the cash position. Managing this leverage effectively will be important for long-term financial stability. The company generates $141.6M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at -33.0%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 2.0% is on the lower side, which is common in asset-heavy industries. Revenue has been relatively flat, moving from $3.92B (2022) to $3.68B (2025).
Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence DENTSPLY SIRONA Inc.'s trajectory.